Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000005216 | SCV000220958 | likely pathogenic | Usher syndrome type 1F | 2014-12-15 | criteria provided, single submitter | literature only | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000005216 | SCV000699764 | pathogenic | Usher syndrome type 1F | 2017-06-15 | criteria provided, single submitter | clinical testing | Variant summary: The PCDH15 c.7C>T (p.Arg3X) variant results in a premature termination codon, predicted to cause a truncated or absent PCDH15 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One truncation downstream of this position have been classified as pathogenic by our laboratory (e.g. c.733C>T, p.Arg245X). One in silico tool predicts a damaging outcome for this variant. This variant was found in 1/108974 control chromosomes at a frequency of 0.0000092, which does not exceed the estimated maximal expected allele frequency of a pathogenic PCDH15 variant (0.0031623). This variant has been reported in multiple studies in patients with USH syndrome, in both homozygotes and heterozygotes (Ahmed_AJHG_2001, Jaijo_BMB_2010, Roux_Invest Ophthalmol Vis Sci_2011), with the UMD-PCDH15 database reporting this variant in 14 patients. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as pathogenic. |
Laboratory for Molecular Medicine, |
RCV000824737 | SCV000710846 | pathogenic | Rare genetic deafness | 2017-02-07 | criteria provided, single submitter | clinical testing | The p.Arg3X variant in PCDH15 has been reported in 10 individuals with Usher syn drome (including 7 homozygous and 1 compound heterozygous) and segregated with d isease in 10 affected relatives from 2 families (Alagramam 2001, Roux 2011, Ahme d 2008, Ahmed 2001, Aparisi 2014, Bonnet 2016, Jaijo 2009, Perreault-Micale 2014 ). This variant has been identified in (1/14512) of Asian chromosomes by the Exo me Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1378530 01); however, this low frequency in the general population is consistent with th e carrier frequency for recessive hearing loss. This nonsense variant leads to a premature termination codon at position 3, which is predicted to lead to a trun cated or absent protein. Loss of PCDH15 function is an established disease mecha nism for Usher syndrome. In summary, this variant meets criteria to be classifie d as pathogenic for autosomal recessive Usher syndrome based on its presence in the homozygous or compound heterozygous state in multiple affected individuals, segregation with disease in multiple affected relatives, extremely low frequency in the general population, and its predicted impact on the protein. |
Labcorp Genetics |
RCV000808283 | SCV000948385 | pathogenic | not provided | 2022-11-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg3*) in the PCDH15 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCDH15 are known to be pathogenic (PMID: 11398101, 11487575, 14570705). This variant is present in population databases (rs137853001, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with Usher syndrome (PMID: 11487575, 25404053, 27440999, 27460420). ClinVar contains an entry for this variant (Variation ID: 4931). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV000808283 | SCV001250219 | pathogenic | not provided | 2016-10-01 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV000005216 | SCV003761098 | pathogenic | Usher syndrome type 1F | 2023-01-24 | criteria provided, single submitter | curation | The p.Arg3Ter variant in PCDH15 has been reported in 4 individuals with Usher syndrome type 1F (PMID: 11487575, 18719945, 27460420, 31541171), segregated with disease in 5 affected relatives from 2 families (PMID: 18719945, 11487575), and has been identified in 0.007% (2/30248) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs137853001). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 4931) and has been interpreted as pathogenic or likely pathogenic by multiple laboratories. Of the 4 affected individuals, 3 of those were homozygotes, which increases the likelihood that the p.Arg3Ter variant is pathogenic (PMID: 11487575, 18719945, 27460420). This nonsense variant leads to a premature termination codon at position 3, which is predicted to lead to a truncated or absent protein. Loss of function of the PCDH15 gene is an established disease mechanism in autosomal recessive Usher syndrome type 1F. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome type 1F. ACMG/AMP Criteria applied: PVS1, PM3, PM2_supporting, PP1_strong (Richards 2015). |
Baylor Genetics | RCV000770851 | SCV004200775 | pathogenic | Autosomal recessive nonsyndromic hearing loss 23 | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005041988 | SCV005677285 | pathogenic | Autosomal recessive nonsyndromic hearing loss 23; Usher syndrome type 1D; Usher syndrome type 1F | 2024-01-02 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000005216 | SCV000025394 | pathogenic | Usher syndrome type 1F | 2001-07-01 | no assertion criteria provided | literature only | |
Genetic Testing Center for Deafness, |
RCV000770851 | SCV000902353 | pathogenic | Autosomal recessive nonsyndromic hearing loss 23 | 2019-02-26 | no assertion criteria provided | case-control | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000808283 | SCV001979530 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000808283 | SCV001979949 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000005216 | SCV002086092 | pathogenic | Usher syndrome type 1F | 2020-07-21 | no assertion criteria provided | clinical testing |